Items where authors include "Cannon, C.P."

Article

Åkerblom, A., James, S.K., Lakic, T.G. et al. (9 more authors) (2019) Interleukin‐18 in patients with acute coronary syndromes. Clinical Cardiology, 42 (12). pp. 1202-1209. ISSN 0160-9289

Cavender, M.A. orcid.org/0000-0002-4466-4760, White, W.B., Liu, Y. et al. (7 more authors) (2018) Total Cardiovascular Events Analysis of the EXAMINE Trial in Patients with Type 2 Diabetes and Recent Acute Coronary Syndrome. Clinical Cardiology, 41 (8). pp. 1022-1027. ISSN 0160-9289

Hwang, Y.-C., Morrow, D.A., Cannon, C.P. et al. (8 more authors) (2018) High-sensitivity C-reactive Protein, Low-Density Lipoprotein Cholesterol, and Cardiovascular Outcomes in Patients with Type 2 Diabetes in the EXAMINE (Examination of Cardiovascular Outcomes With Alogliptin Versus Standard of Care) Trial. Diabetes, Obesity and Metabolism, 20 (3). pp. 654-659. ISSN 1462-8902

Lowenstern, A., Storey, R.F. orcid.org/0000-0002-6677-6229, Neely, M. et al. (12 more authors) (2017) Platelet-related biomarkers and their response to inhibition with aspirin and p2y12-receptor antagonists in patients with acute coronary syndrome. Journal of Thrombosis and Thrombolysis, 44 (2). pp. 145-153. ISSN 0929-5305

Lindholm, D., Hagström, E., James, S.K. et al. (10 more authors) (2017) Growth differentiation factor 15 at 1 month after an acute coronary syndrome is associated with increased risk of major bleeding. Journal of the American Heart Association, 6 (4). ISSN 2047-9980

Andell, P., James, S.K., Cannon, C.P. et al. (10 more authors) (2015) Ticagrelor versus clopidogrel in patients with acute coronary syndromes and chronic obstructive pulmonary disease: An analysis from the platelet inhibition and patient outcomes (PLATO) trial. Journal of the American Heart Association, 4 (10). e002490. ISSN 2047-9980